sv3asr
As filed with the
Securities and Exchange Commission on September 9,
2009
Registration
No. 333-
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form S-3
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
THE TIMKEN
COMPANY
(Exact name of registrant as
specified in its charter)
|
|
|
Ohio
|
|
34-0577130
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
1835 Dueber Avenue,
S.W.
Canton, Ohio
44706-2798
(330) 438-3000
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
Scott A. Scherff
Corporate Secretary and Vice
PresidentEthics and Compliance
1835 Dueber Avenue,
S.W.
Canton, Ohio
44706-2798
(330) 438-3000
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copies To:
Michael J. Solecki
Jones Day
901 Lakeside Avenue
Cleveland, Ohio 44114
Telephone: (216)
586-3939
Facsimile: (216)
579-0212
Approximate date of commencement of proposed sale to the
public: From time to time after this Registration
Statement becomes effective.
If the only securities being registered on this Form are being
offered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest
reinvestment plans, please check the following
box. þ
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this Form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following
box. þ
If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed
to register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following
box. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer þ
|
Accelerated
filer o
|
Non-accelerated
filer o
|
Smaller reporting
company o
|
(Do not check if a smaller
reporting company)
CALCULATION OF
REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed maximum
|
|
|
|
Proposed maximum
|
|
|
|
Amount of
|
|
Title of each class of
|
|
|
Amount to be
|
|
|
|
offering
|
|
|
|
aggregate
|
|
|
|
registration
|
|
securities to be registered
|
|
|
registered(1)
|
|
|
|
price per
unit(1)
|
|
|
|
offering
price(1)
|
|
|
|
fee(1)
|
|
Debt Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
An indeterminate aggregate initial
offering price or number of debt securities is being registered
as may from time to time be issued at indeterminate prices. In
accordance with Rules 456(b) and 457(r), the registrant is
deferring payment of all of the registration fee.
|
Prospectus
The Timken
Company
Debt
Securities
We may offer and sell from time to time our debt securities. We
may sell these debt securities in one or more offerings at
prices and on other terms to be determined at the time of
offering.
We will provide the specific terms of the debt securities to be
offered in one or more supplements to this prospectus. You
should read this prospectus and the applicable prospectus
supplement carefully before you invest in our debt securities.
This prospectus may not be used to offer and sell our debt
securities unless accompanied by a prospectus supplement
describing the method and terms of the offering of those offered
debt securities.
We may offer our debt securities through agents, underwriters or
dealers or directly to investors. Each prospectus supplement
will provide the amount, price and terms of the plan of
distribution relating to the debt securities to be sold pursuant
to such prospectus supplement. We will set forth the names of
any underwriters or agents in the accompanying prospectus
supplement, as well as the net proceeds we expect to receive
from such sale. In addition, the underwriters, if any, may
over-allot a portion of the debt securities.
Investing in any of our debt securities involves risk. Please
read carefully the section entitled Risk factors on
page 6 of this prospectus.
Our common stock is listed on the New York Stock Exchange under
the symbol TKR. If we decide to seek a listing of
any debt securities offered by this prospectus, we will disclose
the exchange or market on which the debt securities will be
listed, if any, or where we have made an application for
listing, if any, in one or more supplements to this prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
The date of this prospectus is
September 9, 2009
About this
prospectus
This prospectus is part of a registration statement that we
filed with the Securities and Exchange Commission using a
shelf registration process. Under this shelf
registration process, we may from time to time sell the debt
securities described in this prospectus in one or more offerings
at prices and on other terms to be determined at the time of
offering.
This prospectus provides you with a general description of the
debt securities we may offer. Each time we sell debt securities,
we will provide a prospectus supplement that will contain more
specific information about the terms of that offering. For a
more complete understanding of the offering of the debt
securities, you should refer to the registration statement,
including its exhibits. The prospectus supplement may also add,
update or change information contained in this prospectus. You
should read both this prospectus and any prospectus supplement
together with additional information under the heading
Where you can find additional information and
Incorporation of certain information by reference.
You should rely only on the information contained or
incorporated by reference in this prospectus and in any
prospectus supplement or in any free writing prospectus that we
may provide to you. We have not authorized anyone to provide you
with different information. You should not assume that the
information contained in this prospectus, any prospectus
supplement or any document incorporated by reference is accurate
as of any date other than the date mentioned on the cover page
of these documents. We are not making offers to sell the debt
securities in any jurisdiction in which an offer or solicitation
is not authorized or in which the person making such offer or
solicitation is not qualified to do so or to anyone to whom it
is unlawful to make an offer or solicitation.
References in this prospectus to the terms we,
us, the Company or Timken or
other similar terms mean The Timken Company and its consolidated
subsidiaries, unless we state otherwise or the context indicates
otherwise.
Where you can
find additional information
We are subject to the informational reporting requirements of
the Securities Exchange Act of 1934. We file annual, quarterly
and current reports, proxy statements and other information with
the SEC. Our SEC filings are available over the Internet at the
SECs website at www.sec.gov. You may read and copy any
reports, statements and other information filed by us at the
SECs Public Reference Room at 100 F Street,
N.E., Washington, D.C. 20549. Please call
1-800-SEC-0330
for further information on the Public Reference Room. You may
also inspect our SEC reports and other information at the New
York Stock Exchange, 20 Broad Street, New York, New York
10005.
We make available free of charge, on or through our website, our
annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K,
and amendments to these reports, as soon as reasonably
practicable after we electronically file such material with, or
furnish such material to, the SEC. You may access these
documents on the Investors section of our website at
www.timken.com. Information contained on or accessible through
our website is not part of this prospectus, other than the
documents that we file with the SEC that are incorporated by
reference into this prospectus.
1
Incorporation of
certain information by reference
The SEC allows us to incorporate by reference into
this prospectus the information in documents we file with it,
which means that we can disclose important information to you by
referring you to those documents. The information incorporated
by reference is considered to be a part of this prospectus, and
information that we file later with the SEC will automatically
update and supersede this information. Any statement contained
in any document incorporated or deemed to be incorporated by
reference herein shall be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement
contained in or omitted from this prospectus or any accompanying
prospectus supplement, or in any other subsequently filed
document which also is or is deemed to be incorporated by
reference herein, modifies or supersedes such statement. Any
such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of
this prospectus.
We incorporate by reference the documents listed below and any
future filings we make with the SEC under Sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934 until
the completion of the offering of securities described in this
prospectus:
|
|
|
our annual report on
Form 10-K
for the year ended December 31, 2008;
|
|
|
our quarterly reports on
Form 10-Q
for the quarters ended March 31, 2009 and June 30,
2009; and
|
|
|
our current reports on
Form 8-K,
as filed with the SEC on March 2, 2009, July 15, 2009,
July 29, 2009, September 2, 2009 and September 9, 2009.
|
We will not, however, incorporate by reference in this
prospectus any documents or portions thereof that are not deemed
filed with the SEC, including any information
furnished pursuant to Item 2.02 or Item 7.01 of our
current reports on
Form 8-K
unless, and except to the extent, specified in such current
reports.
You may obtain copies of these filings without charge by
requesting the filings in writing or by telephone at the
following address.
The Timken
Company
1835 Dueber Avenue, S.W.
Canton, Ohio
44706-2798
Telephone Number:
(330) 438-3000
Attn: Corporate Secretary and Vice PresidentEthics and
Compliance
2
Disclosure
regarding forward-looking statements
Certain statements contained in or incorporated by reference
into this prospectus and any accompanying prospectus supplement
constitute forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements are based upon managements
current expectations, estimates, assumptions and beliefs
concerning future events and conditions and may discuss, among
other things, anticipated future performance (including sales
and earnings), expected growth and future business plans. Any
statement that is not historical in nature is a forward-looking
statement and may be identified by the use of words and phrases
such as expects, anticipates,
believes, will, will likely
result, will continue, plans to
and similar expressions. Readers are cautioned not to place
undue reliance on any forward-looking statements.
Forward-looking statements are necessarily subject to risks,
uncertainties and other factors, many of which are outside of
our control, that could cause actual results to differ
materially from such statements and from our historical results
and experience.
These risks, uncertainties and other factors include such things
as:
|
|
|
continued weakness in world economic conditions, including
additional adverse effects from the global economic slowdown,
terrorism or hostilities, including, but not limited to,
political risks associated with the potential instability of
governments and legal systems in countries in which we or our
customers conduct business, and changes in currency valuations;
|
|
|
the effects of fluctuations in customer demand on sales, product
mix and prices in the industries in which we operate, including
our ability to respond to the rapid changes in customer demand,
the effects of customer bankruptcies or liquidations, the impact
of changes in industrial business cycles and whether conditions
of fair trade continue in the U.S. markets;
|
|
|
competitive factors, including changes in market penetration,
increasing price competition by existing or new foreign and
domestic competitors, the introduction of new products by
existing and new competitors and new technology that may impact
the way our products are sold or distributed;
|
|
|
changes in operating costs, including: the effect of changes in
our manufacturing processes; changes in costs associated with
varying levels of operations and manufacturing capacity; higher
cost and availability of raw materials and energy; our ability
to mitigate the impact of fluctuations in raw materials and
energy costs and the operation of our surcharge mechanism;
changes in the expected costs associated with product warranty
claims; changes resulting from inventory management and cost
reduction initiatives and different levels of customer demands;
the effects of unplanned work stoppages; and changes in the cost
of labor and benefits;
|
|
|
the success of our operating plans, including our ability to
achieve the benefits from our ongoing continuous improvement and
rationalization programs; the ability of acquired companies to
achieve satisfactory operating results; our ability to integrate
the operations of acquired companies; and our ability to
maintain appropriate relations with unions that represent our
associates in certain locations in order to avoid disruptions of
business;
|
|
|
unanticipated litigation, claims or assessments, including, but
not limited to, claims or problems related to intellectual
property, product liability or warranty, environmental issues,
and taxes;
|
3
|
|
|
changes in worldwide financial markets, including the
availability of financing and impact on interest rates, to the
extent they: affect our liquidity or our ability to raise
capital or increase our cost of funds, including the ability to
refinance our unsecured notes; have an impact on the overall
performance of our pension fund investments;
and/or cause
changes in the global economy and financial markets which affect
customer demand and the ability of customers to obtain financing
to purchase our products or equipment which contains our
products; and
|
|
|
our ability to successfully complete the sale of our needle
roller bearings operations.
|
Additional risks relating to our business, the industries in
which we operate or our debt securities may be described from
time to time in our filings with the SEC. All of these risk
factors are difficult to predict, are subject to material
uncertainties that may affect actual results and may be beyond
our control.
Except as required by the federal securities laws, we undertake
no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future
events or otherwise.
Our
business
The Timken Company is a leading global manufacturer of highly
engineered anti-friction bearings and assemblies, high-quality
alloy steels and aerospace power transmission systems, as well
as a provider of related products and services. We operate under
two business groups: the Steel Group and the Bearings and Power
Transmission Group. The Bearings and Power Transmission Group is
composed of three operating segments: Mobile Industries, Process
Industries and Aerospace and Defense. These three operating
segments and the Steel Group comprise our four reportable
segments.
Mobile industries
segment
The Mobile Industries segment provides bearings, power
transmission components and related products and services.
Customers of the Mobile Industries segment include original
equipment manufacturers and suppliers for passenger cars, light
trucks, medium and heavy-duty trucks, rail cars, locomotives and
agricultural, construction and mining equipment. Customers also
include aftermarket distributors of automotive products.
Process
industries segment
The Process Industries segment provides bearings, power
transmission components and related products and services.
Customers of the Process Industries segment include original
equipment manufacturers of power transmission, energy and heavy
industries machinery and equipment, including rolling mills,
cement and aggregate processing equipment, paper mills,
sawmills, printing presses, cranes, hoists, drawbridges, wind
energy turbines, gear drives, drilling equipment, coal conveyors
and crushers and food processing equipment. Customers also
include aftermarket distributors of products other than those
for steel and automotive applications.
4
Aerospace and
defense segment
The Aerospace and Defense segment manufactures bearings,
helicopter transmission systems, rotor head assemblies, turbine
engine components, gears and other precision flight-critical
components for commercial and military aviation applications.
The Aerospace and Defense segment also provides aftermarket
services, including repair and overhaul of engines,
transmissions and fuel controls, as well as aerospace bearing
repair and component reconditioning. In addition, the Aerospace
and Defense segment manufactures bearings for original equipment
manufacturers of health and positioning control equipment.
Steel
group
The Steel segment manufactures more than 450 grades of carbon
and alloy steel, which are produced in both solid and tubular
sections with a variety of lengths and finishes. The Steel
segment also manufactures custom-made steel products for both
industrial and automotive applications.
Corporate
information
Our principal executive offices are located at 1835 Dueber
Avenue, S.W., Canton,
Ohio 44706-2798.
Our main telephone number is
(330) 438-3000,
and our Internet website address is www.timken.com. The
information contained on or accessible through our website is
not part of this prospectus, other than the documents that we
file with the SEC that are incorporated by reference in this
prospectus.
5
Risk
factors
Investing in our debt securities involves risk. Prior to making
a decision about investing in our debt securities, you should
carefully consider the specific factors discussed under the
heading Risk Factors in our most recent annual
report on
Form 10-K
and in our most recent quarterly reports on
Form 10-Q,
which are incorporated herein by reference and may be amended,
supplemented or superseded from time to time by other reports we
file with the SEC in the future. The risks and uncertainties we
have described are not the only ones we face. Additional risks
and uncertainties that are not yet identified may also
materially harm our business, operating results and financial
condition and could result in a complete loss of your investment.
6
Use of
proceeds
Unless we inform you otherwise in the applicable prospectus
supplement, we expect to use the net proceeds from the sale of
our debt securities to which this prospectus relates for general
corporate purposes. These purposes may include, but are not
limited to:
|
|
|
reduction or refinancing of outstanding indebtedness or other
corporate obligations;
|
|
|
additions to working capital;
|
|
|
capital expenditures; and
|
|
|
acquisitions.
|
Pending any specific application, we may initially invest funds
in short-term marketable securities or apply them to the
reduction of short-term indebtedness.
Ratio of earnings
to fixed charges
The following table sets forth our ratio of consolidated
earnings to fixed charges for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months
|
|
|
|
|
|
|
ended June 30,
|
|
|
Year ended December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
|
Ratio of Earnings to Fixed Charges
|
|
|
|
|
|
|
8.44
|
x
|
|
|
5.97
|
x
|
|
|
5.45
|
x
|
|
|
7.30
|
x
|
|
|
4.86
|
x
|
|
|
Fixed charges represent interest expense,
capitalized interest and the portion of rental expense
representing the interest factor for continuing operations.
Earnings represent the aggregate of income from
continuing operations before extraordinary items (excluding
undistributed earnings of unconsolidated entities), income
taxes, net adjustments for capitalized interest and fixed
charges deducted from earnings. For the six months ended
June 30, 2009, earnings were insufficient to cover fixed
charges by $87.8 million. Accordingly, no ratio is
presented for the six months ended June 30, 2009.
7
Description of
debt securities
The following is a general description of the debt securities
that we may offer from time to time under this prospectus. The
financial terms and other specific terms of the debt securities
being offered will be described in a prospectus supplement
relating to the issuance of those securities. The extent, if
any, to which the following general provisions apply to
particular debt securities will be described in the applicable
prospectus supplement.
The debt securities will be issued under an indenture (the
Indenture), between us and The Bank of New York
Mellon Trust Company, N.A. (as successor to The Bank of New
York), as trustee (the Trustee), as may be
supplemented or amended from time to time. A copy of the
Indenture has been filed as an exhibit to the registration
statement of which this prospectus is a part. The Indenture, and
any supplemental indentures thereto, will be subject to, and
governed by, the Trust Indenture Act of 1939.
The following description of general terms relating to the debt
securities and the Indenture is a summary only and does not
describe every aspect of the debt securities that we may offer
pursuant to this prospectus. This summary also is subject to and
qualified by reference to the description of the particular
terms of the debt securities and the Indenture described in the
related prospectus supplement, including definitions of certain
terms used in the Indenture, and the notes. The particular terms
of the debt securities that we may offer under this prospectus
and the Indenture may vary from the terms described below. You
should read the Indenture and the prospectus supplement
regarding any particular issuance of debt securities.
For purposes of this description of debt securities, references
to the terms we, us, the
Company or Timken or other similar terms mean
only The Timken Company and not its consolidated subsidiaries.
General
The Indenture will not limit the aggregate amount of debt
securities that may be issued. The debt securities may be issued
from time to time in more than one series and may be issued at a
discount from their stated principal amount and in any currency
designated by us.
Unless otherwise specified in the prospectus supplement, our
debt securities will be general unsecured obligations. Any
senior debt securities that we offer will rank equally with all
of our other unsecured, unsubordinated obligations. Any
subordinated debt securities that we issue will rank junior in
right of payment to all of our senior indebtedness to the extent
and in the manner set forth in the applicable prospectus
supplement. In addition, our subsidiaries are separate and
distinct legal entities and will have no obligation to pay any
amounts due on the debt securities or to provide us with the
funds to satisfy our payment obligations. As a result, any debt
securities that we issue will be effectively subordinated to all
existing and future indebtedness and other liabilities of our
subsidiaries.
The applicable prospectus supplement accompanying this
prospectus will describe the terms of the particular series of
debt securities we are offering, including:
|
|
|
the title of the debt securities;
|
|
|
any limit on the aggregate principal amount of the debt
securities of the series that may be authenticated and delivered
under the Indenture;
|
8
|
|
|
the price of the debt securities, expressed as a percentage of
the principal amount;
|
|
|
the date or dates on which the principal of, and any premium on,
the debt securities will be payable, or the method for
determining the date or dates;
|
|
|
the rate or rates (which may be fixed or variable) at which the
debt securities of the series shall bear interest, if any, or
the method of determining such rate or rates, the date or dates
from which such interest shall accrue, the interest payment
dates on which such interest shall be payable or the method by
which such dates will be determined, the record dates for the
determination of holders thereof to whom such interest is
payable, and the basis upon which interest will be calculated if
other than that of a
360-day year
of twelve
30-day
months;
|
|
|
the place or places where the principal of, premium, if any, and
any interest, if any, on debt securities of the series shall be
payable or the method of such payment, if by wire transfer, mail
or by other means; and the place or places where notices or
demands to or upon us in respect of the debt securities and the
Indenture may be served, if, in each case, other than as
provided in the Indenture;
|
|
|
our obligation, if any, to redeem, purchase, or repay debt
securities of the series pursuant to any sinking fund or
analogous provisions or at the option of a holder thereof and
the price or prices at which, the period or periods within
which, and the terms and conditions upon which debt securities
of the series shall be redeemed, purchased, or repaid, in whole
or in part, pursuant to such obligations;
|
|
|
the price or prices at which, the period or periods within
which, and the terms and conditions upon which debt securities
of the series may be redeemed, in whole or in part, at our
option or otherwise;
|
|
|
if other than the Trustee, the identity of the trustee,
authenticating or paying agents, transfer agents, or registrars
for the debt securities of the series;
|
|
|
if other than denominations of $1,000 or any integral multiple
thereof, the denominations in which debt securities of the
series shall be issuable;
|
|
|
if other than the principal amount thereof, the portion of the
principal amount of debt securities of the series that shall be
payable upon declaration of acceleration of the maturity thereof;
|
|
|
any additions or changes to the events of default in the
Indenture;
|
|
|
any additions or changes with respect to the other covenants in
the Indenture;
|
|
|
whether the amount of any payments on the debt securities may be
determined with reference to an index, formula or other method,
and the manner in which such amounts are to be determined;
|
|
|
the terms and conditions of any warrants that we may offer in
connection with the debt securities of any series;
|
|
|
the forms of the debt securities of the series and whether the
debt securities will be issuable, in whole or in part, as global
notes, and the terms and conditions, if any, upon which such
global note or notes may be exchanged in whole or in part for
other individual debt securities, and the depositary for such
global note and debt securities, if other than as set forth in
the Indenture;
|
9
|
|
|
the provisions, if any, relating to any security provided for
the debt securities of the series;
|
|
|
the terms and conditions, if any, upon which additional interest
or amounts may be payable with respect to debt securities of any
series;
|
|
|
any other terms of the series (which terms may modify,
supplement or delete any provision of the Indenture with respect
to such series; provided, however, that no such term may modify
or delete any provision in the Indenture if imposed by the Trust
Indenture Act; and provided, further, that any modification or
deletion of the rights, duties or immunities of the Trustee
under the Indenture shall have been consented to in writing by
the Trustee);
|
|
|
the terms and conditions, if any, upon which the debt securities
of the series shall be exchanged for or converted into other
securities of the Company or securities of another person;
|
|
|
any depositories, interest rate calculation agents or other
agents with respect to debt securities of such series if other
than those appointed in the Indenture;
|
|
|
whether the debt securities of such series are subject to
subordination and any modification of, or addition to the
provisions regarding the subordination of debt securities in the
Indenture, and whether such debt securities rank as senior
subordinated notes or subordinated notes or any combination
thereof; and
|
|
|
the securities exchange or quotation system, if any, upon which
debt securities of any series will be listed or quoted and any
CUSIP number, if any.
|
The prospectus supplement may also describe special federal
income tax consequences of the debt securities, including any
special U.S. federal income tax, accounting and other
considerations applicable to original issue discount securities.
An original issue discount security is a debt security,
including any zero-coupon debt security, which:
|
|
|
is issued at a price lower than the amount payable upon its
stated maturity; and
|
|
|
provides that, upon redemption or acceleration of the maturity,
an amount less than the amount payable upon the stated maturity
will become due and payable.
|
In addition, the material U.S. federal income tax or other
considerations applicable to any debt securities that are
denominated in a currency or currency unit other than
U.S. dollars will be described in the applicable prospectus
supplement.
We will have the ability, in addition to the ability to issue
debt securities with terms different from those of debt
securities previously issued, without the consent of the
holders, to reopen a previous issue of a series of debt
securities and issue additional debt securities of that series
in an aggregate principal amount determined by us, unless the
reopening was restricted when the series was created. All debt
securities issued as a series, including those issued pursuant
to any reopening of a series, will vote together as a single
class.
10
Consolidation,
merger or sale
Unless otherwise noted in the applicable prospectus supplement,
the Indenture will limit our ability to merge, consolidate, or
sell, convey, transfer, lease or otherwise dispose of all or
substantially all of our assets, unless:
|
|
|
any successor corporation is a corporation organized under the
laws of the United States of America or any state thereof;
|
|
|
the successor corporation expressly assumes all of our
obligations under the applicable Indenture and any debt
securities issued under the Indenture;
|
|
|
there is no event of default immediately after giving effect to
the merger, consolidation or sale; and
|
|
|
certain other conditions are met.
|
Covenants
Under the Indenture, we will agree to:
|
|
|
maintain an office or agency as a place of payment;
|
|
|
pay the principal and interest on the debt securities of any
series;
|
|
|
deposit sufficient funds with any paying agent or trust, on and
before the due date for any principal, interest or premium;
|
|
|
certain limitations with respect to the incurrence of
liens; and
|
|
|
certain limitations with respect to sale-leaseback transactions
that we may enter into.
|
Any additional restrictive covenants applicable to any
particular series of debt securities will be described in a
prospectus supplement.
Events of default
under the indenture
Unless otherwise indicated in a prospectus supplement, the
following will be events of default under the Indenture with
respect to any series of debt securities issued:
|
|
|
failure to pay interest when due, if the failure continues for
30 days;
|
|
|
failure to pay the principal or premium, if any, when due;
|
|
|
failure to observe or perform any other covenant contained in
the applicable series of debt securities or the Indenture, other
than a covenant specifically relating to another series of debt
securities, if the failure continues for 90 days after the
Company receives notice from the Trustee or holders of at least
25% in aggregate principal amount of the outstanding debt
securities of that series;
|
|
|
failure to make payment of any sinking fund installment, if the
failure continues for 30 days; and
|
|
|
certain events of bankruptcy, insolvency or reorganization of
the Company, but not of its subsidiaries.
|
11
A particular series of debt securities may include additional
events of default or changes to the events of default described
above. If any additional or different events of default apply to
a particular series of debt securities, they will be described
in the prospectus supplement relating to that series.
If an event of default with respect to debt securities (other
than a bankruptcy default) of any series occurs and is
continuing, the Indenture trustee or the holders of at least 25%
in aggregate principal amount of the outstanding debt securities
of that series, by notice in writing to us, and to the Indenture
trustee if notice is given by those holders, may declare the
unpaid principal of, premium, if any, and accrued interest, if
any, due and payable immediately. If a bankruptcy default occurs
with respect to us, the principal of, premium, if any, and
accrued interest on each series of debt securities issued under
the Indenture will become immediately due and payable without
any declaration or other act of the Trustee or the holders.
The holders of a majority in principal amount of the outstanding
debt securities of an affected series may waive any default or
event of default with respect to the series and its
consequences, except defaults or events of default regarding
payment of principal, premium, if any, or interest.
Any waiver will be deemed to cure the default or event of
default to which the waiver relates.
Subject to the terms of the Indenture, if an event of default
occurs and is continuing, the Trustee will be under no
obligation to exercise any of its rights or powers under the
Indenture at the request or direction of any of the holders of
the applicable series of debt securities, unless such holders
have offered the Trustee reasonable indemnity. The holders of a
majority in principal amount of the outstanding debt securities
of any series will have the right to direct the time, method and
place of conducting any proceeding for any remedy available to
the Trustee, or exercising any trust or power conferred on the
Trustee, with respect to the debt securities of that series,
provided that:
|
|
|
it is not in conflict with any law or the Indenture;
|
|
|
the Trustee may take any other action deemed proper by it which
is not inconsistent with the direction; and
|
|
|
subject to its duties under the Trust Indenture Act of
1939, the Trustee need not take any action that might involve it
in personal liability or might be unduly prejudicial to the
holders not involved in the proceeding.
|
A holder of debt securities of any series will only have the
right to institute a proceeding under the Indenture or to
appoint a receiver or another trustee, or to seek other
remedies, if:
|
|
|
the holder has given written notice to the Trustee of a
continuing event of default with respect to that series;
|
|
|
the holders of at least 25% in aggregate principal amount of the
outstanding debt securities of that series have made a written
request therefor, and the holders have offered indemnity
reasonably satisfactory to the Trustee to institute the
proceedings as trustee; and
|
|
|
the Trustee does not institute the proceeding and does not
receive from the holders of a majority in aggregate principal
amount of the outstanding debt securities of that series other
conflicting directions within 60 days after the notice,
request and offer.
|
These limitations do not apply to a suit instituted by a holder
of debt securities if we default in the payment of the principal
of, premium, if any, or interest on the debt securities.
12
Subordination of
subordinated debt securities
The payment of the principal of, premium, if any, and interest
on any series of subordinated debt securities we may issue under
the Indenture will rank junior in right of payment to the prior
payment in full of all senior indebtedness, as defined in the
Indenture, to the extent described in the prospectus supplement
accompanying such series.
Defeasance and
covenant defeasance
Unless the prospectus supplement describes otherwise, we will
have two options to discharge our obligations under a series of
debt securities before its maturity date. These options are
known as legal defeasance and covenant
defeasance. Legal defeasance means that we will be deemed
to have paid the entire amount of the applicable series of debt
securities and we will be released from all of our obligations
relating to that series (except for certain obligations, such as
registering transfers of the debt securities). Covenant
defeasance means that as to the applicable series of debt
securities, we will not have to comply with certain covenants as
described in the Indenture.
To elect either legal defeasance or covenant defeasance for any
series of debt securities, we must deposit with the Trustee an
amount of money
and/or
U.S. government obligations that will be sufficient to pay
principal of, and interest and any premium or sinking fund
payments on, the debt securities when those amounts are
scheduled to be paid. In addition, we must provide a legal
opinion stating that as a result of the legal defeasance or
covenant defeasance holders will not be required to recognize
income, gain or loss for federal income tax purposes and will be
subject to federal income tax on the same amounts, in the same
manner and at the same times as if the legal defeasance or
covenant defeasance had not occurred. For legal defeasance, that
opinion must be based on either an Internal Revenue Service
ruling or a change in law since the date of the Indenture. We
must also meet other conditions, such as there being no events
of default. The amount deposited with the Trustee can be
decreased at a later date if, in the opinion of a nationally
recognized firm of independent public accountants, the deposits
are greater than the amount then needed to pay principal of, and
interest and any premium or sinking fund payments on, the debt
securities when those amounts are scheduled to be paid.
Our obligations relating to the debt securities will be
reinstated if the Trustee is unable to pay the debt securities
with the deposits held in trust, due to an order of any court or
governmental authority. It is possible that a series of debt
securities for which we elect covenant defeasance may later be
declared immediately due in full because of an event of default
(not relating to the covenants that were defeased). If that
happens, we must pay the debt securities in full at that time
using the deposits held in trust or other money.
Modification of
indenture; waiver
We and the Trustee may, without the consent of any holders,
change the terms of the Indenture with respect to certain
matters, including:
|
|
|
to cure any ambiguity, omission, defect or inconsistency in the
Indenture;
|
|
|
to change any provision if the change does not materially
adversely affect the interests of any holder of debt securities
of the applicable series;
|
13
|
|
|
to provide for the assumption, by a successor person or the
acquiror of all or substantially all of our assets, of our
obligations under the Indenture and the debt securities issued
under the Indenture;
|
|
|
to provide for conversion rights in certain events;
|
|
|
to add any additional events of default;
|
|
|
to add to our covenants for the benefit of holders of debt
securities of any series or to surrender any right or power
conferred upon us; and
|
|
|
to comply with any requirement in connection with the
qualification of an Indenture under the Trust Indenture Act.
|
In addition, under the Indenture, we may change the rights of
holders of a series of debt securities and the Indenture trustee
with the written consent of the holders of at least a majority
in aggregate principal amount of the outstanding debt securities
of each series that is affected. However, the following changes
may only be made with the consent of each holder of any
outstanding debt securities affected:
|
|
|
changing the stated maturity of the principal of, or any
installment of interest on, any such series of debt securities;
|
|
|
reducing the principal amount, reducing the rate of or extending
the time of payment for interest, or reducing any premium
payable upon the redemption of any debt securities;
|
|
|
change the place or currency of payment of principal of, or
premium, if any, or interest on, any debt securities; or
|
|
|
impair a holders right to initiate suit for the
enforcement of any payment on or with respect to any debt
security.
|
In addition, any reduction in the percentage of principal amount
of debt securities, the holders of which are required to consent
to any amendment, modification or waiver under the Indenture or
a particular series of debt securities will require the
affirmative consent of at least the percentage of debt
securities which would originally have been required to make
such consent, modification or waiver effective.
Form, exchange
and transfer
Unless otherwise indicated in the applicable prospectus
supplement, debt securities of each series will be issuable only
in fully registered form without coupons and in denominations of
$1,000 and integral multiples of $1,000. The Indenture will
provide that debt securities of a series may be issuable in
temporary or permanent global form and may be issued as
book-entry securities that will be deposited with, or on behalf
of, The Depository Trust Company or another depositary
named by us and identified in a prospectus supplement with
respect to the series.
The following provisions will apply to depositary arrangements.
A global security to be deposited with or on behalf of a
depositary will be registered in its name or the name of its
nominee. The depositary will, upon deposit of the global
security, credit the accounts of the institutions that have
accounts with the depositary that have been designated by the
underwriters, agents or us.
Beneficial interests in global securities will be limited to
institutions that are depositary participants or persons that
hold interests through them. Ownership and transfer of
beneficial
14
interests will be recorded in the books maintained by the
depositary or its nominee. The laws of some jurisdictions
require physical delivery of securities that might impair
transfers of beneficial interests in a global security.
The depositary or its nominee registered as the owner of such
global security will be treated by us as the sole owner for all
purposes under the Indenture and the particular series of debt
securities. Unless the prospectus supplement provides otherwise,
each owner of a beneficial interest must rely on the procedures
of the depositary and participants in the depositary, if
applicable, to exercise its rights as a holder of an interest in
a global security.
We, the Trustee, any paying agent and the registrar of debt
securities will have no responsibility or liability for any
aspect of the records relating to, or to record payments made on
account of, beneficial ownership interests.
If the depositary for any debt securities represented by a
global security is at any time unwilling or unable to continue
as depositary or ceases to be a clearing agency registered under
the Securities Exchange Act of 1934, we will appoint an eligible
successor depositary. If we fail to appoint an eligible
successor depositary within 90 days, individual debt
securities of that series will be issued in exchange for the
global security. In addition, we may, at any time and in our
sole discretion, determine not to have any debt securities of a
series represented by one or more global securities. In that
event, individual debt securities of that series will be issued
in exchange for the global security representing that series of
debt securities. Unless we so specify with respect to the debt
securities of a series, an owner of a beneficial interest in a
global security representing debt securities of that series may
not receive individual debt securities of that series in
exchange for its beneficial interests.
To the extent material and not otherwise described in this
prospectus, the prospectus supplement will describe the method
of payment of principal of, and interest and premium, if any,
on, a global security. Payments of principal of, and premium and
interest on, debt securities will be made to the registered
depositary or its nominee.
At the option of the holder, subject to the terms of the
Indenture and any limitations applicable to global securities
described in the applicable prospectus supplement, debt
securities of any series will be exchangeable for other debt
securities of the same series, of like tenor and aggregate
principal amount, in any authorized denomination.
Subject to the terms of the Indenture, and any limitations
applicable to global securities described in the applicable
prospectus supplement, debt securities duly endorsed or with the
form of transfer endorsed thereon and duly executed if so
required by us or the registrar, may be presented for exchange
or for registration of transfer at the office of the registrar
or at the office of any paying agent designated by us for that
purpose. Unless otherwise provided in the debt securities to be
transferred or exchanged, no service charge will be made for any
registration of transfer or exchange, but we may require payment
of any taxes or other governmental charges. We have initially
designated the Trustee as registrar and paying agent, and any
additional registrars or paying agents will be named in the
applicable prospectus supplement. We may at any time designate
additional paying agents or registrars, rescind the designation
of any office or approve a change in the office through which
any paying agent or registrar acts, except that we will be
required to maintain a paying agent in each place of payment for
the debt securities of each series, and a registrar in each
place where the debt securities of each series may be presented
for registration of transfer.
15
If the debt securities of any series are to be redeemed, the
Trustee will not be required to:
|
|
|
issue, register the transfer of or exchange any debt securities
of that series during a period beginning at the opening of
business 15 days before the day of mailing of a notice of
redemption of the debt securities that may be selected for
redemption and ending at the close of business on the day of
that mailing; or
|
|
|
register the transfer of or exchange any debt securities so
selected for redemption, in whole or in part, except the
unredeemed portion of any debt securities being redeemed in part.
|
Regarding the
trustee
The Trustee, other than when an event of default with respect to
a particular series of debt securities has occurred and is
continuing, will undertake to perform only such duties as are
specifically set forth in the Indenture and, upon an event of
default with respect to a particular series of debt securities,
will be required to use the same degree of care as a prudent
person would exercise or use in the conduct of his or her own
affairs. Subject to this provision, the Trustee is under no
obligation to exercise any of the powers given it by the
Indenture at the request of any holder of debt securities unless
it is offered reasonable security and indemnity against the
costs, expenses and liabilities that it might incur. The Trustee
is not required to spend or risk its own money or otherwise
become financially liable while performing its duties unless it
reasonably believes that it will be repaid or receive indemnity
reasonably satisfactory to it.
Paying agents and
payment
Unless otherwise indicated in the applicable prospectus
supplement, the payment of interest on any debt securities on
any interest payment date will be made to the person in whose
name such debt securities, or one or more predecessor
securities, are registered at the close of business on the
regular record date for the payment of such interest.
Principal of and premium, if any, and interest on the debt
securities of a particular series will be payable at the office
of the paying agents designated by us, except that unless
otherwise indicated in the applicable prospectus supplement,
premium, if any, and interest payments may be made by check
mailed to the holder. Unless otherwise indicated in such
prospectus supplement, the corporate trust office of the Trustee
in the City of New York will be designated as our sole paying
agent for payments with respect to debt securities of each
series. Any other paying agents initially designated by us for
the debt securities of a particular series will be named in the
applicable prospectus supplement. We will be required to
maintain a paying agent in each place of payment for the debt
securities of a particular series.
All moneys paid by us to a paying agent or the Trustee for the
payment of the principal of, or premium, if any, or interest on
any debt securities which remains unclaimed at the end of two
years after the principal, premium, if any, or interest has
become due and payable will be repaid to us, and after that time
the holder of the security may look only to us for payment of
those amounts.
Governing
law
The Indenture and the debt securities will be governed by and
construed in accordance with the laws of the State of New York.
16
Plan of
distribution
We may sell the offered debt securities in and outside the
United States:
|
|
|
through underwriters or dealers;
|
|
|
directly to purchasers;
|
|
|
through agents; or
|
|
|
through a combination of any of these methods.
|
The prospectus supplement will include the following information:
|
|
|
the terms of the offering;
|
|
|
the names of any underwriters or agents;
|
|
|
the name or names of any managing underwriter or underwriters;
|
|
|
the purchase price or initial public offering price of the debt
securities;
|
|
|
the net proceeds from the sale of the debt securities;
|
|
|
any delayed delivery arrangements;
|
|
|
any underwriting discounts, commissions and other items
constituting underwriters compensation;
|
|
|
any discounts or concessions allowed or reallowed or paid to
dealers;
|
|
|
any commissions paid to agents; and
|
|
|
any securities exchanges on which the debt securities may be
listed.
|
Sale through
underwriters or dealers
If underwriters are used in the sale, we will execute an
underwriting agreement with them regarding the debt securities.
The underwriters will acquire the debt securities for their own
account, subject to conditions in the underwriting agreement.
The underwriters may resell the debt securities from time to
time in one or more transactions, including negotiated
transactions, at a fixed public offering price or at varying
prices determined at the time of sale. Underwriters may offer
the debt securities to the public either through underwriting
syndicates represented by one or more managing underwriters or
directly by one or more firms acting as underwriters. Unless we
inform you otherwise in the prospectus supplement, the
obligations of the underwriters to purchase the debt securities
will be subject to certain conditions, and the underwriters will
be obligated to purchase all the offered debt securities if they
purchase any of them. The underwriters may change from time to
time any initial public offering price and any discounts or
concessions allowed or reallowed or paid to dealers.
During and after an offering through underwriters, the
underwriters may purchase and sell the debt securities in the
open market. To the extent expressly set forth in the applicable
prospectus supplement, these transactions may include
over-allotment and stabilizing transactions and purchases to
cover syndicate short positions created in connection with the
offering. The underwriters may also impose a penalty bid, which
means that selling concessions allowed to syndicate members or
other broker-dealers for the offered debt securities sold for
their account may be reclaimed by the syndicate if the offered
debt securities are repurchased by the syndicate in stabilizing
or covering transactions. These activities may stabilize,
maintain or otherwise affect the market price of the offered
debt securities, which may be higher than the price that might
otherwise prevail in the open market. If commenced, the
underwriters may discontinue these activities at any time.
Some or all of the debt securities that we offer though this
prospectus may be new issues of debt securities with no
established trading market. Any underwriters to whom we sell our
debt
17
securities for public offering and may make a market in those
debt securities, but they will not be obligated to do so and
they may discontinue any market making at any time without
notice. Accordingly, we cannot assure you of the liquidity of,
or continued trading markets for, any debt securities that we
offer.
If dealers are used in the sale of the debt securities, we will
sell the debt securities to them as principals. They may then
resell the debt securities to the public at varying prices
determined by the dealers at the time of resale. We will include
in the prospectus supplement the names of the dealers and the
terms of the transaction.
Direct sales and
sales through agents
We may sell the debt securities directly. In this case, no
underwriters or agents would be involved. We may also sell the
debt securities through agents designated from time to time. In
the prospectus supplement, we will name any agent involved in
the offer or sale of the offered debt securities, and we will
describe any commissions payable to the agent. Unless we inform
you otherwise in the prospectus supplement, any agent will agree
to use its reasonable best efforts to solicit purchases for the
period of its appointment.
We may sell the debt securities directly to institutional
investors or others who may be deemed to be underwriters within
the meaning of the Securities Act with respect to any sale of
those securities. We will describe the terms of any sales of
these debt securities in the prospectus supplement.
Remarketing
arrangements
Offered debt securities may also be offered and sold, if so
indicated in the applicable prospectus supplement, in connection
with a remarketing upon their purchase, in accordance with a
redemption or repayment pursuant to their terms, or otherwise,
by one or more remarketing firms, acting as principals for their
own accounts or as agents for us. Any remarketing firm will be
identified and the terms of its agreements, if any, with us and
its compensation will be described in the applicable prospectus
supplement.
Delayed delivery
contracts
If we so indicate in the prospectus supplement, we may authorize
agents, underwriters or dealers to solicit offers from certain
types of institutions to purchase debt securities from us at the
public offering price under delayed delivery contracts. These
contracts would provide for payment and delivery on a specified
date in the future. The contracts would be subject only to those
conditions described in the prospectus supplement. The
prospectus supplement will describe the commission payable for
solicitation of those contracts.
General
information
We may have agreements with the agents, dealers, underwriters
and remarketing firms to indemnify them against certain civil
liabilities, including liabilities under the Securities Act of
1933, or to contribute with respect to payments that the agents,
dealers, underwriters or remarketing firms may be required to
make. Agents, dealers, underwriters and remarketing firms may be
customers of, engage in transactions with or perform services
for us in the ordinary course of their businesses.
Legal
matters
Jones Day will pass upon the validity of the debt securities
being offered hereby.
18
Experts
The consolidated financial statements of The Timken Company
appearing in The Timken Companys Annual Report
(Form 10-K)
for the year ended December 31, 2008 and the effectiveness
of The Timken Companys internal control over financial
reporting as of December 31, 2008, have been audited by
Ernst & Young LLP, independent registered public
accounting firm, as set forth in their reports thereon included
therein, and incorporated herein by reference. Such financial
statements have been incorporated herein by reference in
reliance upon such reports given on the authority of such firm
as experts in accounting and auditing.
19
Part II
Information not
required in prospectus
|
|
Item 14.
|
Other expenses
of issuance and distribution.
|
The following are the estimated expenses of the issuance and
distribution of the securities being registered, all of which
are payable by us.
|
|
|
|
|
|
Securities and Exchange Commission registration fee
|
|
|
*
|
|
Trustees fees and expenses
|
|
|
**
|
|
Transfer agent and registrar fees
|
|
|
**
|
|
Printing expenses
|
|
|
**
|
|
Accountants fees and expenses
|
|
|
**
|
|
Legal fees and expenses
|
|
|
**
|
|
Miscellaneous
|
|
|
**
|
|
Total
|
|
$
|
**
|
|
|
|
|
|
|
*
|
|
Because the amount to be registered
consists of an unspecified amount of the debt securities as may
from time to time be offered at indeterminate prices, in
accordance with Rules 456(b) and 457(r) under the
Securities Act of 1933, the registrant is deferring payment of
the registration fee.
|
|
**
|
|
Estimated expenses are presently
not known and cannot be estimated.
|
|
|
Item 15.
|
Indemnification
of directors and officers.
|
Under Ohio law, Ohio corporations are authorized to indemnify
directors, officers, employees and agents within prescribed
limits and must indemnify them under certain circumstances. Ohio
law does not provide statutory authorization for a corporation
to indemnify directors, officers, employees and agents for
settlements, fines or judgments in the context of derivative
suits. However, it provides that directors (but not officers,
employees and agents) are entitled to mandatory advancement of
expenses, including attorneys fees, incurred in defending
any action, including derivative actions, brought against the
director, provided that the director agrees to cooperate with
the corporation concerning the matter and to repay the amount
advanced if it is proved by clear and convincing evidence that
his act or failure to act was done with deliberate intent to
cause injury to the corporation or with reckless disregard of
the corporations best interests.
Ohio law does not authorize payment of judgments to a director,
officer, employee or agent after a finding of negligence or
misconduct in a derivative suit absent a court order.
Indemnification is permitted, however, to the extent such person
succeeds on the merits. In all other cases, if a director,
officer, employee or agent acted in good faith and in a manner
he reasonably believed to be in or not opposed to the best
interests of the corporation, indemnification is discretionary
except as otherwise provided by a corporations articles,
code of regulations or by contract except with respect to the
advancement of expenses of directors.
Under Ohio law, a director is not liable for monetary damages
unless it is proved by clear and convincing evidence that his
action or failure to act was undertaken with deliberate intent
to cause injury to the corporation or with reckless disregard
for the best interests of the corporation. There is, however, no
comparable provision limiting the liability of officers,
employees or agents of a corporation. The statutory right to
indemnification is not exclusive in Ohio, and Ohio corporations
may, among other things, procure insurance for such persons.
II-1
Article IV of our Amended Regulations provides that we
shall indemnify our directors, officers and employees, and may
indemnify our agents, to the fullest extent permitted by law
under various conditions and subject to various qualifications,
and reads as follows:
Section 1.
Indemnification
The Corporation shall indemnify, to the fullest extent then
permitted by law, any person who was or is a party or is
threatened to be made a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal,
administrative or investigative, by reason of the fact that he
is or was a Director, officer, employee or agent of the
Corporation, or is or was serving at the request of the
Corporation as a director, trustee, officer, employee or agent
of another corporation, domestic or foreign, non-profit or for
profit, partnership, joint venture, trust or other enterprise,
provided, however, that the Corporation shall indemnify any such
agent (as opposed to any Director, officer or employee) of the
Corporation to an extent greater than that required by law only
if and to the extent that the Directors may, in their
discretion, so determine, and provided, further, that the
Corporation shall not be required hereby to indemnify any person
with respect to any action, suit or proceeding that was
initiated by such person unless such action, suit or proceeding
was initiated by such person to enforce any rights to
indemnification arising hereunder and such person shall have
been formally adjudged to be entitled to indemnity by reason
hereof. The indemnification provided hereby shall not be deemed
exclusive of any other rights to which those seeking
indemnification may be entitled under any law, the Articles of
Incorporation or any agreement, vote of shareholders of
disinterested Directors or otherwise, both as to action in
official capacities and as to action in another capacity while
he is a Director, officer, employee or agent of the Corporation,
and shall continue as to a person who has ceased to be a
Director, trustee, officer, employee or agent and shall inure to
the benefit of the heirs, executors and administrators of such a
person.
Section 2.
Insurance
The Corporation may, to the full extent then permitted by law,
purchase and maintain insurance on behalf of any persons
described in Section 1 of this Article IV against any
liability asserted against and incurred by any such person in
any such capacity, or arising out of his status as such, whether
or not the Corporation would have the power to indemnify such
person against such liability.
Section 3.
Indemnification agreements
The Corporation may, to the fullest extent then permitted by
law, enter into indemnification agreements with any person
described in Section 1 of this Article IV.
We have entered into contracts with some of our directors and
officers that indemnify them against many of the types of claims
that may be made against them. We also maintain insurance
coverage for the benefit of directors and officers with respect
to many types of claims that may be made against them, some of
which may be in addition to those described in our Amended
Regulations.
II-2
The following documents are exhibits to the registration
statement:
|
|
|
|
|
Exhibit
|
|
|
number
|
|
Description
|
|
|
1
|
.1
|
|
Underwriting Agreement*
|
|
4
|
.1
|
|
Indenture between The Timken Company and The Bank of New York
Mellon Trust Company, N.A. (as successor to The Bank of New
York), as Trustee, dated as of February 18, 2003, filed on
March 27, 2003, as Exhibit 4.7 to the annual report on
Form 10-K
(Commission File
No. 1-1169),
and incorporated herein by reference.
|
|
5
|
.1
|
|
Opinion of Jones Day.
|
|
12
|
.1
|
|
Calculation of Ratio of Earnings to Fixed Charges.
|
|
23
|
.1
|
|
Consent of Ernst & Young LLP, Independent Registered
Public Accounting Firm.
|
|
23
|
.2
|
|
Consent of Jones Day (included in Exhibit 5.1 to this
Registration Statement).
|
|
24
|
.1
|
|
Power of Attorney.
|
|
25
|
.1
|
|
Form T-1
Statement of Eligibility under Trust Indenture Act of 1939
of Trustee.
|
|
|
|
*
|
|
To be filed either by amendment or
as an exhibit to a report filed under the Securities Exchange
Act of 1934, and incorporated herein by reference.
|
The undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) To include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20 percent change in the
maximum aggregate offering price set forth in the
Calculation of Registration Fee table in the
effective registration statement; and
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
provided, however, that paragraphs (1)(i), (1)(ii) and
(1)(iii) do not apply if the information required to be included
in a post-effective amendment by those paragraphs is contained
in periodic reports filed with or furnished to the Commission by
the registrant pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934 that are incorporated by
II-3
reference in this registration statement, or is contained in a
form of prospectus filed pursuant to Rule 424(b) that is
part of this registration statement.
2. That, for the purpose of determining any liability under
the Securities Act of 1933, each such post-effective amendment
shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial
bona fide offering thereof.
3. To remove from registration by means of a post-effective
amendment any of the securities being registered which remain
unsold at the termination of the offering.
4. That, for the purpose of determining liability under the
Securities Act of 1933 to any purchaser:
(i) Each prospectus filed by the registrant pursuant to
Rule 424(b)(3) shall be deemed to be part of the
registration statement as of the date the filed prospectus was
deemed part of and included in the registration
statement; and
(ii) Each prospectus required to be filed pursuant to
Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration
statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii), or (x) for
the purpose of providing the information required by
Section 10(a) of the Securities Act of 1933 shall be deemed
to be a part of and included in the registration statement as of
the earlier date such form of prospectus is first used after
effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As
provided in Rule 430B, for liability purposes of the issuer
and any person that is at that date an underwriter, such date
shall be deemed to be a new effective date of the registration
statement relating to the securities in the registration
statement to which that prospectus relates, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however,
that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is a part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or
made in any such document immediately prior to such effective
date.
5. That, for the purpose of determining liability of the
registrant under the Securities Act of 1933 to any purchaser in
the initial distribution of the securities the undersigned
registrant undertakes that in a primary offering of securities
of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered
or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such
securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the
undersigned registrant relating to the offering required to be
filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrant or used
or referred to by the undersigned registrant;
II-4
(iii) The portion of any other free writing prospectus
relating to the offering containing material information about
the undersigned registrant or its securities provided by or on
behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the
offering made by the undersigned registrant to the purchaser.
The undersigned registrant hereby undertakes that, for purposes
of determining any liability under the Securities Act of 1933,
each filing of the registrants annual report pursuant to
Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plans annual report pursuant to
Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in this
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
The undersigned registrant hereby undertakes to supplement the
prospectus, after the expiration of the subscription period, to
set forth the results of the subscription offer, the
transactions by the underwriters during the subscription period,
the amount of unsubscribed securities to be purchased by the
underwriters, and the terms of any subsequent reoffering
thereof. If any public offering by the underwriters is to be
made on terms differing from those set forth on the cover page
of the prospectus, a post-effective amendment will be filed to
set forth the terms of such offering.
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors,
officers and controlling persons of the registrant pursuant to
the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as
expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and
will be governed by the final adjudication of such issue.
II-5
Signatures
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
City of Canton, State of Ohio, on September 9, 2009.
THE TIMKEN COMPANY
|
|
|
|
By
|
/s/ Glenn
A. Eisenberg
|
Glenn A. Eisenberg, Executive
Vice PresidentFinance and Administration
Pursuant to the requirements of the Securities Act of 1933, this
registration statement on
Form S-3
has been signed below by the following persons in the capacities
indicated as of September 9, 2009:
|
|
|
|
|
Signatures
|
|
Title
|
|
*
James
W. Griffith
|
|
President, Chief Executive Officer and Director
(Principal Executive Officer)
|
/s/ Glenn
A. Eisenberg
Glenn
A. Eisenberg
|
|
Executive Vice PresidentFinance and Administration
(Principal Financial Officer)
|
*
J.
Ted Mihaila
|
|
Senior Vice President and Controller
(Principal Accounting Officer)
|
*
Phillip
R. Cox
|
|
Director
|
*
Jerry
J. Jasinowski
|
|
Director
|
*
John
A. Luke, Jr.
|
|
Director
|
*
Joseph
W. Ralston
|
|
Director
|
*
John
P. Reilly
|
|
Director
|
*
Frank
C. Sullivan
|
|
Director
|
*
John
M. Timken, Jr.
|
|
Director
|
II-6
|
|
|
|
|
Signatures
|
|
Title
|
|
|
|
Director
|
|
|
Director
|
|
|
Director
|
|
|
|
*
|
|
The undersigned by signing his name
hereto does sign and execute this registration statement on
Form S-3
pursuant to the Power of Attorney executed by the above-named
directors and officers of the registrant, which is being filed
herewith on behalf of such directors and officers.
|
|
|
|
By:
|
/s/ Glenn
A. Eisenberg
|
|
Glenn A. Eisenberg, Attorney-in-fact
September 9, 2009
II-7
Index to
exhibits
|
|
|
|
|
Exhibit
|
|
|
number
|
|
Description
|
|
|
1
|
.1
|
|
Underwriting Agreement*
|
|
4
|
.1
|
|
Indenture between The Timken Company and The Bank of New York
Mellon Trust Company, N.A. (as successor to The Bank of New
York), as Trustee, dated as of February 18, 2003, filed on
March 27, 2003, as Exhibit 4.7 to the annual report on
Form 10-K
(Commission File
No. 1-1169),
and incorporated herein by reference.
|
|
5
|
.1
|
|
Opinion of Jones Day.
|
|
12
|
.1
|
|
Calculation of Ratio of Earnings to Fixed Charges.
|
|
23
|
.1
|
|
Consent of Ernst & Young LLP, Independent Registered
Public Accounting Firm.
|
|
23
|
.2
|
|
Consent of Jones Day (included in Exhibit 5.1 to this
Registration Statement).
|
|
24
|
.1
|
|
Power of Attorney.
|
|
25
|
.1
|
|
Form T-1
Statement of Eligibility under Trust Indenture Act of 1939
of Trustee.
|
|
|
|
*
|
|
To be filed either by amendment or
as an exhibit to a report filed under the Securities Exchange
Act of 1934, and incorporated herein by reference.
|